World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ANZCTR
Last refreshed on: 13 January 2020
Main ID:  ACTRN12614001087640
Date of registration: 10/10/2014
Prospective Registration: Yes
Primary sponsor: Queensland University of Technology
Public title: The Younger Women's Wellness after Cancer program: A pilot study of an E-Health Enabled Lifestyle Modification Intervention.
Scientific title: The Younger Women's Wellness after Cancer program: A pilot study of an E-Health Enabled Lifestyle Modification Intervention to Improve the Health and Wellness of Younger Women after Cancer Treatment.
Date of first enrolment: 29/05/2015
Target sample size: 80
Recruitment status: Stopped early
URL:  https://anzctr.org.au/ACTRN12614001087640.aspx
Study type:  Interventional
Study design:  Purpose: Educational / counselling / training; Allocation: Randomised controlled trial; Masking: Blinded (masking used);Assignment: Parallel;Type of endpoint: Efficacy;  
Phase:  Not Applicable
Countries of recruitment
Australia
Contacts
Name: Prof Debra Anderson    
Address:  School of Nursing and Midwifery Menzies Health Institute Queensland Griffith University 58 Parklands Dr, Southport QLD 4215, Australia Australia
Telephone: +61 7 555 28403
Email: debra.anderson@griffith.edu.au
Affiliation: 
Name: Ms Janine Porter-Steele   
Address:  Griffith University | Menzies Health Institute Gold Coast Campus Clinical Sciences 2 (G16), Gold Coast. QLD. Australia. 4222 Australia
Telephone: +61 7 55 528935 +61 466 269 562
Email: j.porter-steele@griffith.edu.au
Affiliation: 
Key inclusion & exclusion criteria
Inclusion criteria: (1) Completed surgery or chemotherapy (primary or adjuvant) and/or radiotherapy for blood, breast and/or gynaecological cancer (2) Able to speak and read Level 10 English (3) Must have access to internet (4) not currently receiving any cytotoxic maintenance treatments
Exclusion criteria: (1) Metastatic or advanced cancer and inoperable or active loco-regional disease (2) Any clinical, cognitive or psychiatric contraindication identified by treating staff (3) Participants on cytotoxic maintenance treatments will be excluded

Age minimum: 20 Years
Age maximum: 50 Years
Gender: Females
Health Condition(s) or Problem(s) studied
Cancer - Cervical (cervix)
Cancer - Breast
Breast Cancer ;Gynaecological cancer;Haematological cancer;
Breast Cancer
Gynaecological cancer
Haematological cancer
Cancer - Ovarian and primary peritoneal
Intervention(s)
The intervention is a 12 week, e-health enabled, structured health promotion intervention targeted at improving health related quality of life and reducing chronic disease risk factors in women between 20 and 50 years of age who have previously been treated for breast, haematological and gynaecological cancers. All women in the intervention arm will receive health education material, including a Program Journal (in the form of an interactive iBook), and access to an interactive web interface. The iBook includes sections on healthy eating, sleep, exercise advice, tips for managing fatigue and stress, mindfulness, and will encourage women to bring together these various components of the health education provided and incorporate them into their lives over a 12-week period. The iBook includes a weekly exercise planner, where women are encouraged to use this journal daily and to plan ahead for their exercise in the following week. Participants will receive access to self-directed resources (via the website) and personal consultations (via videoconference) with a nurse. Three individual, virtual 30 minute consultations at 0, 6 and 12 weeks will be provided by a registered nurse trained in the intervention.
Primary Outcome(s)
The primary outcome measure is change in health-related quality of life as measured by The Functional Assessment of Cancer Therapy-General (FACT-G)[Baseline, 12 weeks and 24 weeks ]
Secondary Outcome(s)
Habitual dietary intake will be monitored through the Food Frequency Questionnaire [Baseline, 12 weeks and 24 weeks ]
Menopausal symptoms - Greene Climacteric Scale[Baseline, 12 weeks and 24 weeks ]
Internet and technology use. This will be assessed with 13 questions incorporated into the online survey (e.g. how often do you access the internet?; have you ever used health-related mobile apps?; how often to you access health forums?) [Baseline, 12 weeks and 24 weeks ]
Stress, anxiety and depression - Perceived Stress, and List of Threatening Experiences (LTE), Connor-Davidson Resilience Scale, Zung self-rated anxiety scale, Centre for Epidemiologic Studies Depression Scale.[Baseline, 12 weeks and 24 weeks ]
Body image, sexuality and sexual function. These will be assessed with validated tools incorporated into the online survey (the Body Image Scale, the Female Sexual Function Index, and the Emotional Intimacy Scale). [Baseline, 12 weeks and 24 weeks]
Health behaviours, including smoking and alcohol consumption, will be assessed in the online survey at baseline (0 weeks), 12 week and 24 weeks. Alcohol consumption is also measured as part of the Food Frequency Questionnaire (described above).[Baseline, 12 weeks and 24 weeks]
Physical activity will be measured using the validated International Physical Activity Questionnaire (IPAQ)[Baseline, 12 weeks and 24 weeks ]
Sleep activity and quality - Pittsburgh sleep quality index [Baseline, 12 weeks and 24 weeks ]
The FACT-Cog tool has been included in the online component of the survey and is a 37 questionnaire assessing cognitive function. [baseline, 12 weeks and 24 weeks]
Anthropometry using standard protocols; including measures of height, weight, waist-to-hip ratio and BMI.[Baseline, 12 weeks and 24 weeks ]
Secondary ID(s)
NIL
Source(s) of Monetary Support
Princess Alexandra Hospital.
Royal Brisbane and Women's Hospital - Diamond Care Grant
Secondary Sponsor(s)
Royal Brisbane and Women's Hospital
Ethics review
Status: Approved
Approval date:
Contact:
Royal Brisbane Women's Hospital Human Research Ethics Committee
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history